Skip to content

Post intubation hemodynamic effects of intravenous lidocaine in patients with severe brain trauma

Post intubation hemodynamic effects of intravenous lidocaine in patients with severe brain trauma

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013042813150N1
Enrollment
100
Registered
2013-05-08
Start date
2013-04-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with severe head trauma. Intracranial injury

Interventions

Intervention 1: In the control group patients before intubation only common protocols (conventional pharmacological protocol for patients with head trauma (succinylcholine 1.5 mg / kg + rapid intraven
Treatment - Drugs
In the control group patients before intubation only common protocols (conventional pharmacological protocol for patients with head trauma (succinylcholine 1.5 mg / kg + rapid intravenous fentanyl 2 m
Intervention group patients before intubation in addition to standard protocols (conventional pharmacological protocol for patients with head trauma (succinylcholine 1.5 mg / kg + rapid intravenous fe

Sponsors

Vice-chancellor for research, Tabriz University of Medical Sciences, Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: all patients aged 65-18 years with traumatic brain injury with GCS <9; patients who have been intubated prior to admission to the emergency room; before referring patients to the emergency room, and inotropic drugs have not received isotonic fluids. Exclusion criteria: patients aged 18 years and above 65 year; patients with heart failure; in patients with shock, hypovolemia, sepsis and cardiogenic reason; patients with a previous history of heart disease and hypertension; start inotropic drugs before intubation and evidence of cardiac arrhythmia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Heart Rate. Timepoint: Once before and once after intubation. Method of measurement: by an automatic blood pressure cuff.;Systolic Arterial pressure. Timepoint: Once before and once after intubation. Method of measurement: by an automatic blood pressure cuff.;Diastolic arterial pressure. Timepoint: Once before and once after intubation. Method of measurement: by an automatic blood pressure cuff.;Mean arterial pressure. Timepoint: Once before and once after intubation. Method of measurement: by an automatic blood pressure cuff.

Secondary

MeasureTime frame
The rate of use of isotonic fluids. Timepoint: After intubation. Method of measurement: Chart of Fluids.;The rate of use of inotropic agents. Timepoint: After intubation. Method of measurement: Chart of drugs.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr mohammad Ali Najjari Asl

Tabriz University of Medical Sciences

ali_njr@yahoo.com+98 41 1658 6302

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026